AmerisourceBergen names Leslie Donato chief strategy officer
AmerisourceBergen has named Leslie Donato to its executive team as executive vice president and chief strategy officer. In this role, Donato will focus on operationalizing and evolving a strategic framework for the organization, while identifying and implementing a range of growth initiatives that will add further value for its customers.
“At AmerisourceBergen, we are committed to taking bold, innovative action that reinforces our position as a leader in the market, and I’m delighted to welcome Leslie to the team that will continue driving this momentum forward,” AmerisourceBergen chairman, president and CEO Steve Collis said. “Leslie brings with her an impressive track record of identifying robust and sustainable growth strategies for complex, global healthcare organizations. Her understanding and knowledge of today’s industry landscape, as well as her proven leadership and ability to transform multifaceted strategies into meaningful results provides an ideal foundation to evolve our strategic approach, ultimately fortifying our customer’s success and enhancing our growth.”
Donato brings nearly 30 years of long-range strategy and healthcare industry experience. Most recently at Bayer Pharmaceuticals, she developed an integrated global pharmaceutical strategy and a U.S. growth strategy, oversaw the U.S. business for both hematology and neurology, and led the global strategic marketing team for neurology.
Prior to Bayer, she was a partner at McKinsey & Company, specializing in healthcare. Throughout her tenure, Donato has developed extensive expertise in understanding global business development, accelerating strategic growth, driving company transformation and re-design and empowering employee engagement, the company said.
Donato will report directly to Collis and will be based out of AmerisourceBergen’s Conshohocken, Pa., office.
No comments found